Latest News and Press Releases
Want to stay updated on the latest news?
-
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
-
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
-
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
-
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
-
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
-
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
-
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
-
BRUSSELS, Belgium, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source foundations, has unveiled the agenda and speakers for the inaugural Open...
-
Oncocyte Announces August Investor Conferences Participation
-
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8